BRPI0508365A - immunogenic compositions for chlamydia pneumoniae - Google Patents
immunogenic compositions for chlamydia pneumoniaeInfo
- Publication number
- BRPI0508365A BRPI0508365A BRPI0508365-6A BRPI0508365A BRPI0508365A BR PI0508365 A BRPI0508365 A BR PI0508365A BR PI0508365 A BRPI0508365 A BR PI0508365A BR PI0508365 A BRPI0508365 A BR PI0508365A
- Authority
- BR
- Brazil
- Prior art keywords
- chlamydia pneumoniae
- immunogenic compositions
- self
- polypeptide
- individual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
COMPOSIçõES IMUNOGêNICAS PARA CHLAMYDIA PNEUMONIAE. A invenção se refere aos polipeptídeos para uso como um antígeno autotransportador. A invenção adicionalmente se refere aos métodos e usos de um polipeptídeo para uma função autotransportadora na preparação de um medicamento para a prevenção ou tratamento de uma infecção por Chlamydia pneumoniae ou para preparação de um ensaio para o diagnóstico de uma infecção por Chlamydia pneumoniae em um indivíduo. Um método também é provido para promoção de uma resposta imune em um indivíduo, por administração ao mesmo de um polipeptídeo para uso como um antígeno autotransportador.IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA PNEUMONIAE. The invention relates to polypeptides for use as a self-supporting antigen. The invention further relates to methods and uses of a polypeptide for a self-supporting function in the preparation of a medicament for the prevention or treatment of a Chlamydia pneumoniae infection or for the preparation of an assay for the diagnosis of a Chlamydia pneumoniae infection in an individual. . A method is also provided for promoting an immune response in an individual by administering to it a polypeptide for use as a self-supporting antigen.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54983204P | 2004-03-02 | 2004-03-02 | |
US64311005P | 2005-01-12 | 2005-01-12 | |
US64455205P | 2005-01-19 | 2005-01-19 | |
PCT/US2005/006588 WO2005084306A2 (en) | 2004-03-02 | 2005-03-02 | Immunogenic compositions for chlamydia pneunomiae |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0508365A true BRPI0508365A (en) | 2007-07-24 |
Family
ID=34923269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0508365-6A BRPI0508365A (en) | 2004-03-02 | 2005-03-02 | immunogenic compositions for chlamydia pneumoniae |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1729800A4 (en) |
JP (1) | JP2007526318A (en) |
BR (1) | BRPI0508365A (en) |
CA (1) | CA2557353A1 (en) |
RU (1) | RU2006134631A (en) |
WO (1) | WO2005084306A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG160329A1 (en) | 2005-02-18 | 2010-04-29 | Novartis Vaccines & Diagnostic | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
CN101203529A (en) | 2005-02-18 | 2008-06-18 | 诺华疫苗和诊断公司 | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
EP2064230A2 (en) | 2006-08-16 | 2009-06-03 | Novartis AG | Immunogens from uropathogenic escherichia coli |
CA2731854C (en) * | 2008-07-25 | 2020-06-30 | Cellestis Limited | Measurement of cell-mediated immune response reactivity to detect or monitor a disease or condition |
WO2010032138A2 (en) | 2008-09-18 | 2010-03-25 | Novartis Ag | Vaccine adjuvant combinations |
ITMI20090946A1 (en) | 2009-05-28 | 2010-11-29 | Novartis Ag | EXPRESSION OF RECOMBINANT PROTEINS |
CN102740882A (en) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | Adjuvant comprising aluminium, oligonucleotide and polycation |
ES2443952T3 (en) | 2009-09-02 | 2014-02-21 | Novartis Ag | Immunogenic compositions that include modulators of TLR activity |
CN102933267B (en) | 2010-05-28 | 2015-05-27 | 泰特里斯在线公司 | Interactive hybrid asynchronous computer game infrastructure |
ES2458355T3 (en) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorption of immunopotentiators on insoluble metal salts |
ES2630029T3 (en) | 2010-12-14 | 2017-08-17 | Glaxosmithkline Biologicals Sa | Flow cytometry analysis of adsorbed materials in metal salts |
RU2013144207A (en) | 2011-03-02 | 2015-04-10 | Новартис Аг | COMBINED VACCINES WITH REDUCED DOSES OF ANTIGEN AND / OR ADJUVANT |
EP2822586A1 (en) | 2012-03-07 | 2015-01-14 | Novartis AG | Adjuvanted formulations of streptococcus pneumoniae antigens |
RU2014140336A (en) | 2012-03-07 | 2016-04-27 | Новартис Аг | IMMUNOLOGICALLY USEFUL ARGININE SALTS |
CA2866406A1 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of booster vaccines |
JP6990522B2 (en) * | 2017-04-11 | 2022-02-03 | シスメックス株式会社 | A method for measuring the immune stimulus response of immune cells, a method for determining the ability of immunological synapses to form in immune cells, and a cell analyzer. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6822071B1 (en) * | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
ATE440861T1 (en) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE |
-
2005
- 2005-03-02 EP EP05724183A patent/EP1729800A4/en not_active Withdrawn
- 2005-03-02 CA CA002557353A patent/CA2557353A1/en not_active Abandoned
- 2005-03-02 WO PCT/US2005/006588 patent/WO2005084306A2/en active Application Filing
- 2005-03-02 RU RU2006134631/13A patent/RU2006134631A/en not_active Application Discontinuation
- 2005-03-02 BR BRPI0508365-6A patent/BRPI0508365A/en not_active IP Right Cessation
- 2005-03-02 JP JP2007501899A patent/JP2007526318A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
RU2006134631A (en) | 2008-04-10 |
EP1729800A4 (en) | 2008-06-11 |
WO2005084306A2 (en) | 2005-09-15 |
CA2557353A1 (en) | 2005-09-15 |
WO2005084306A3 (en) | 2006-05-26 |
EP1729800A2 (en) | 2006-12-13 |
JP2007526318A (en) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0508365A (en) | immunogenic compositions for chlamydia pneumoniae | |
WO2007054279A3 (en) | Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions | |
NL300897I2 (en) | Neisseira meningitidis serogroup B recombinantly lipidated fHbp subfamily A05 protein | |
CL2007003635A1 (en) | COMPOUNDS DERIVED FROM 6-AMINO-PURIN-8-ONA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCESS TO PREPARE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF ALLERGIC, VIRAL OR CANCER DISEASES. | |
BRPI0708519A8 (en) | virosome-like vesicle, pharmaceutical composition, use of at least one virosome-like vesicle, method of treatment and / or prophylaxis of a hiv infection, and kit for inducing an immune response against a gp41 protein of a human immunodeficiency virus | |
DK2280721T3 (en) | Indoleamin-2,3-dioxygenase-based immunotherapy | |
BRPI0409459A (en) | New Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease | |
BRPI0912411B8 (en) | use of a human interleukin-2 mutein (hil-2 mutein) and pharmaceutical composition for the treatment and/or prophylaxis of an autoimmune disease | |
BR112014004860A2 (en) | influenza virus antibody compositions | |
BR112013005907A2 (en) | parenteral pharmaceutical composition, methods for treating and preventing an HIV infection, and use of a pharmaceutical composition | |
WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
UY29377A1 (en) | NEW LIQUID FORMULATIONS OF ROTAVIRUS, ITS PREPARATION AND ITS USES. | |
CO6640289A2 (en) | Compositions of anti-nerve growth factor antibodies (ngf) | |
AR035586A1 (en) | COMPOSITION OF VACCINE, EQUIPMENT, METHODS TO INCREASE THE IMMUNE RESPONSE, USE OF A DERIVATIVE OF 1H-IMIDAZO (4,5-C) QUINOLIN-4-AMINA IN THE MANUFACTURE OF A MEDICINAL PRODUCT, AND COMBINATION OF COMPONENTS FOR SEPARATE, SEQUENTIAL ADMINISTRATION OR CONCOMITANT FOR USE IN DNA VACCINATION | |
WO2008039267A3 (en) | Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions | |
NO20045521L (en) | Diarylurea derivatives useful for the treatment of protein kinase-dependent diseases | |
CO6400149A2 (en) | MYTHATIN LINK PROTEINS | |
BR0107972A (en) | Use of a hiv tat, hiv nef, or hiv tat protein or polynucleotide attached to a hiv nef protein or polynucleotide (nef-tat), and a hiv gp120 protein or polynucleotide, method for immunizing a hiv human being against hiv, and vaccine composition for human use | |
BRPI0821110B8 (en) | anti-nr10/il31ra neutralizing antibody, pharmaceutical composition comprising said antibody and use thereof | |
CL2008003537A1 (en) | 2-aminopyrimidine derived compounds, h4 receptor antagonists; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound in the treatment of an allergic, immunological or inflammatory disease or pain. | |
BRPI0415315A (en) | methods of increasing an immune response to an antigen in a mammal, and reducing the severity of a cancer in a patient, combined preparation, pharmaceutical kit, and, uses an il-18 polypeptide or its bioactive fragment or derivative, and an immunogenic composition | |
WO2007059931A8 (en) | New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions | |
WO2008017826A3 (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof | |
SV2006002290A (en) | NONADEPSIPEPTIDOS ACILADOS II REF. BHC041327-SV | |
ATE458496T1 (en) | HIV VACCINES AND METHODS OF APPLICATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) Free format text: ALTERADO DE: CHIRON CORPORATION |
|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |